We found that the high levels of active TGF-β in RDEB fibroblasts from three different patients, a hallmark of the disease, were diminished following exposure to either raloxifene or NAC, in direct contrast to the increase in endoglin expression. The gene discussed is ENG; the disease is recessive dystrophic epidermolysis bullosa.